The Board of Directors of iNtRON Biotechnology, Inc. has authorized a buyback plan on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,230 KRW | +2.13% | +1.80% | -29.04% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.04% | 146M | |
+14.70% | 118B | |
+12.99% | 106B | |
-3.22% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.43% | 15.56B | |
+4.54% | 13.63B | |
+28.36% | 12.27B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- INtRON Biotechnology, Inc. authorizes a Buyback Plan.